404

Not Found

Is this what you were looking for?

index php brand name cialis overnight index php
By Kelsey Kaustinen

Ongoing acquisition efforts

Though Teva has dropped its offer for Mylan, Mylan's acquisition attempt continues, as the company expects to take its offer to Perrigo's shareholders following the positive vote
By Peter Kissinger

Pediatric pharmacology, part 2

Thanks to a lack of appropriate trials, pharma, healthcare professionals, government, educators, caring/hopeful parents and others are forced to wing it with drugs not fully vetted in the pediatric population
By Kelsey Kaustinen

Abbott announces plans to split, form two companies

Abbott Laboratories has announced that it will be separating into two publicly traded companies, one specializing in diversified medical products and the other in research-based pharmaceuticals.
By Chris Anderson

Magellan says: automate this

After the acquisition of TekCel, Magellan Biosciences indirectly continues to expand its automation instrument empire as TekCel announces its acquisition of ultra-low-temperature sample-management specialist Biophile, Inc., based in Charlottesville, Virginia. Biophile's systems are used for temperature-sensitive work involving DNA, tissue, and tumor storage, and complement the automation systems already in play at TekCel and Magellan Bioscience.
By Kimberely Sirk

Baxter’s buying

After dropping generic injectables, company adds hemophilia-related assets of Archemix to product stable
By Jeffrey Bouley

Start of a new era

Palm Springs plays host to the last distinct LabAutomation meeting as former ALA members look toward mingling with former SBS members in a single annual meeting in 2012

Run a Search

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue